ACP
ERAS icon

Acuta Capital Partners’s Erasca ERAS Stock Holding History

Acuta Capital Partners’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.86M Sell
265,199
-89,376
-25% -$1.28M 3.39% 9
2026
Q1 		$5.74M Buy
+354,575
New +$4.19M 4.05% 7

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Acuta Capital Partners's ERAS Position: Q2 2026 in Review

Acuta Capital Partners reduced its Erasca (ERAS) stake by 25% in Q2 2026, selling an estimated $1.28M and leaving 265,199 shares worth $4.86M. The position accounts for 3.39% of the portfolio, ranked #9.

Acuta Capital Partners first reported a position in ERAS in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.74M in Q1 2026. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Acuta Capital Partners held 265,199 shares of Erasca worth $4.86M as of Q2 2026.
  • Acuta Capital Partners sold 89,376 Erasca shares in Q2 2026, an estimated $1.28M.
  • Erasca made up 3.39% of Acuta Capital Partners's portfolio in Q2 2026, its #9 holding.
  • Acuta Capital Partners first reported a position in Erasca in Q1 2026 and has held it in 2 quarters since.
  • Acuta Capital Partners's Erasca position peaked at $5.74M in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Acuta Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.